SCHEMBL31336002

SCHEMBL31336002

Cc1ccc(S(=O)(=O)n2c(C)cc3cc(C(=O)O)c(O)cc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ ACLY P53396 2/20 0.46
▸ CSNK2A1 P68400 1/20 0.43
▸ AGTR1 P30556 2/20 0.43
▸ PPARG P37231 2/20 0.42
▸ PPARD Q03181 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ MCL1 Q07820 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ NOD2 Q9HC29 1/20 0.41
▸ NOD1 Q9Y239 1/20 0.41
▸ SRC P12931 1/20 0.40
▸ ALDH3A1 P30838 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31335990 0.75 KDM4E (0.50) KDM4ELMNATSHRL3MBTL1MEN1
SCHEMBL28592027 0.75 AGTR1 (0.55) KDM4ELMNATSHRL3MBTL1ACLY
SCHEMBL9805181 0.71 ALDH1A1 (0.53) KDM4ELMNAL3MBTL1CSNK2A1MEN1
SCHEMBL28414053 0.71 NOD1 (0.61) LMNAL3MBTL1AGTR1MEN1KMT2A
SCHEMBL14953583 0.71 PPARG (0.61) LMNAACLYPPARGPPARDMEN1
SCHEMBL1272442 0.71 ACLY (0.48) KDM4ELMNATSHRL3MBTL1ACLY
SCHEMBL14953586 0.71 LMNA (0.55) LMNAPPARGPPARDMEN1KMT2A
SCHEMBL22670414 0.71 LMNA (0.46) KDM4ELMNATSHRL3MBTL1ACLY
SCHEMBL3565182 0.70 PPARG (0.61) ACLYPPARGPPARDMEN1KMT2A
SCHEMBL27247879 0.69 PPARG (0.46) KDM4ELMNATSHRL3MBTL1AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720038-A1 (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES Neophore Limited (GB) 2026-04-08 — — EP disclosed
WO-2024246496-A1 (HETERO)ARYL-CARBONYL-HETEROBICYCLIC COMPOUNDS AS INHIBITORS OF PMS2 FOR CANCER AND DEGENERATIVE ILLNESSES Neophore Limited (GB) 2024-12-05 — — WO disclosed
Send feedback